glioblastoma

Failure in pivotal PhIII brain cancer trial drags Israel’s VBL Therapeutics down
Failure in pivotal PhIII brain cancer trial drags Israel’s VBL Therapeutics down
Endpoints
clinical trials
VBL Therapeutics
VB-111
Roche
Avastin
glioblastoma
Flag link:
The Fastest Growing Cancer Company You've Never Heard Of
The Fastest Growing Cancer Company You've Never Heard Of
Motley Fool
devices
Novocure
tumor treating fields
cancer
TTFields
glioblastoma
ovarian cancer
pancreatic cancer
lung cancer
Flag link:
Bristol-Myers’ checkpoint star Opdivo fails a PhIII study for glioblastoma
Bristol-Myers’ checkpoint star Opdivo fails a PhIII study for glioblastoma
Endpoints
Bristol-Myers Squibb
Opdivo
glioblastoma
brain cancer
clinical trials
Flag link:
FDA Allows Ziopharm Brain Cancer Drug Trial
FDA Allows Ziopharm Brain Cancer Drug Trial
Investopedia
FDA
Ziopharm
brain cancer
clinical trials
Ad-RTS-hIL-12
glioblastoma
Flag link:
CAR-T therapy makes early inroads in treating brain cancer
CAR-T therapy makes early inroads in treating brain cancer
Stat
CAR-T
glioblastoma
brain cancer
Flag link:
Celgene CEO: myeloma and glioblastoma both priorities
Celgene CEO: myeloma and glioblastoma both priorities
BioPharma Dive
Celgene
Multiple Myeloma
glioblastoma
marizomib
R&D
Flag link:
3 Shocking Biotech Flops of 2016 So Far
3 Shocking Biotech Flops of 2016 So Far
Motley Fool
biotech
Rintega
Celldex Therapeutics
glioblastoma
Clovis Oncology
rociletinib
lung cancer
NewLink Genetics
algenpantucel-L
pancreatic cancer
Flag link:
AbbVie Presents Encouraging Phase 1 Data for Investigational Medicine ABT-414 as Monotherapy in Patients with an Aggressive Brain Cancer at the 2016 American Society of Clinical Oncology Annual Meeting
AbbVie Presents Encouraging Phase 1 Data for Investigational Medicine ABT-414 as Monotherapy in Patients with an Aggressive Brain Cancer at the 2016 American Society of Clinical Oncology Annual Meeting
Yahoo
AbbVie
glioblastoma
brain cancer
ASCO 2016
ABT-414
Flag link:
CTRC doctor wins $1.6 million FDA orphan grant to treat deadly brain tumors
CTRC doctor wins $1.6 million FDA orphan grant to treat deadly brain tumors
phys.org
TH-302
Threshold Pharmaceuticals
glioblastoma
brain cancer
Flag link:
Northwest Bio Fuzzier on Cancer Vaccine Study Patient Enrollment
Northwest Bio Fuzzier on Cancer Vaccine Study Patient Enrollment
TheStreet.com
Northwest Biotherapeutics
glioblastoma
DCVax
Flag link:
ImmunoCellular Therapeutics Presents Updated ICT-107 Phase II Data in Patients with Newly Diagnosed Glioblastoma at the 2014 ASCO Annual Meeting
ImmunoCellular Therapeutics Presents Updated ICT-107 Phase II Data in Patients with Newly Diagnosed Glioblastoma at the 2014 ASCO Annual Meeting
Yahoo/PR NewsWire
ImmunoCellular Therapeutics
ICT-107
glioblastoma
Flag link:
Roche May Share Trial Data on Avastin Amid Brain Cancer Conflict
Roche May Share Trial Data on Avastin Amid Brain Cancer Conflict
Bloomberg
Roche
Avastin
glioblastoma
Flag link:
Agenus: How Meaningful Is The Prophage Phase II Data?
Agenus: How Meaningful Is The Prophage Phase II Data?
Seeking Alpha
Agenus
Prophage
glioblastoma
Flag link:
Celldex, ImmunoCellular Fall And Rise On Hype And Hope
Celldex, ImmunoCellular Fall And Rise On Hype And Hope
Seeking Alpha
ImmunoCellular Therapeutics
Celldex
rindopepimut
glioblastoma
ICT-107
Flag link:
Celldex: A View On The Imminent Release Of Data For The Cancer Vaccine Rindopepimut
Celldex: A View On The Imminent Release Of Data For The Cancer Vaccine Rindopepimut
Seeking Alpha
vaccines
glioblastoma
rindopepimut
Celldex
Flag link:
A Promising Platform for Cancer Immunotherapy
A Promising Platform for Cancer Immunotherapy
Motley Fool
Celldex
rindopepimut
glioblastoma
Flag link:
Roche's Avastin fails to prolong survival in brain cancer study
Roche's Avastin fails to prolong survival in brain cancer study
Reuters
Roche
Avastin
glioblastoma
brain cancer
Flag link:
Celldex Releases Data, Biostar Announces Q3 Results Date: Healthcare Business Review
Celldex Releases Data, Biostar Announces Q3 Results Date: Healthcare Business Review
Wall Street Cheat Street
Celldex
rindopepimut
glioblastoma
Biostar Pharmaceuticals
earnings
Flag link:
Threshold announces preliminary data from TH-302 study
Threshold announces preliminary data from TH-302 study
Yahoo/Fly on the Wall
Threshold Pharmaceuticals
TH-302
glioblastoma
Flag link:
Threshold Pharmaceuticals Announces Preliminary Data From Phase 1/2 Study of TH-302 in Combination With Bevacizumab in Patients With Recurrent Glioblastoma
Threshold Pharmaceuticals Announces Preliminary Data From Phase 1/2 Study of TH-302 in Combination With Bevacizumab in Patients With Recurrent Glioblastoma
Yahoo/MarketWire
glioblastoma
bevacizumab
TH-302
Threshold Pharmaceuticals
Flag link:

Pages